Depomed Earnings Conference Call (Q4 2013) Today's Calls 
Visit the TF Network Sites
Visit the TF Network Sites
· Corporate IR Center
· Institutional Investor Center
· Individual Investor Center
Download Plug-In
Real Player 8 Basic
Windows Media Player
Other Conference Calls
Other Mar 12 Calls
Today's Calls
Call Details
Depomed Earnings Conference Call (Q4 2013)
Scheduled to start Wed, Mar 12, 2014, 4:30 pm Eastern

-- this event is ongoing now--
Listen to the ongoing live event audio stream

About Depomed Inc (NasdaqGS:DEPO)
Depomed, Inc., a specialty pharmaceutical company, focuses on developing products for pain and other conditions, and diseases of the central nervous system in the United States. The company primarily offers Gralise (gabapentin), an once-daily product for the management of postherpetic neuralgia; Zipsor (diclofenac potassium) liquid filled capsule, a non-steroidal anti-inflammatory drug for the treatment of mild to moderate acute pain in adults; and Glumetza, a metformin hydrochloride extended release tablets for use in adults with type 2 diabetes. It is also involved in the clinical development of two product candidates, comprising Serada, which completed Phase III clinical trials for the treatment of menopausal hot flashes; and DM-1992 that completed a Phase II trial for Parkinson's disease. The company sells its Gralise products to wholesalers and retail pharmacies. Depomed, Inc. has license and collaboration agreements with Santarus, Inc.; Covidien, Ltd.; Boehringer Ingelheim International GMBH; Ironwood Pharmaceuticals, Inc.; Merck & Co., Inc.; Janssen Pharmaceutica N.V.; Janssen Pharmaceuticals, Inc.; Abbott Products Inc.; Patheon Puerto Rico, Inc.; Valeant Pharmaceuticals International, Inc.; and PharmaNova, Inc. The company was founded in 1995 and is headquartered in Newark, California.

More Info: Quote | Chart | News | Profile | Reports | Research | Msgs | Insider | Financials | Analyst Ratings

Copyright © 2014 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Copyright © 2014 FirstCall Events. Historical chart data provided by Commodity Systems, Inc. (CSI). Company profile information presented on this page is Copyright Capital IQ. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Capital IQ, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.